GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Abaxis Inc (NAS:ABAX) » Definitions » Equity-to-Asset

Abaxis (Abaxis) Equity-to-Asset : 0.85 (As of Mar. 2018)


View and export this data going back to 1992. Start your Free Trial

What is Abaxis Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Abaxis's Total Stockholders Equity for the quarter that ended in Mar. 2018 was $290.7 Mil. Abaxis's Total Assets for the quarter that ended in Mar. 2018 was $341.1 Mil. Therefore, Abaxis's Equity to Asset Ratio for the quarter that ended in Mar. 2018 was 0.85.

The historical rank and industry rank for Abaxis's Equity-to-Asset or its related term are showing as below:

ABAX's Equity-to-Asset is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 0.58
* Ranked among companies with meaningful Equity-to-Asset only.

Abaxis Equity-to-Asset Historical Data

The historical data trend for Abaxis's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abaxis Equity-to-Asset Chart

Abaxis Annual Data
Trend Mar09 Mar10 Mar11 Mar12 Mar13 Mar14 Mar15 Mar16 Mar17 Mar18
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.89 0.82 0.87 0.87 0.85

Abaxis Quarterly Data
Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.87 0.86 0.87 0.83 0.85

Competitive Comparison of Abaxis's Equity-to-Asset

For the Diagnostics & Research subindustry, Abaxis's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Abaxis's Equity-to-Asset Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Abaxis's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Abaxis's Equity-to-Asset falls into.



Abaxis Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Abaxis's Equity to Asset Ratio for the fiscal year that ended in Mar. 2018 is calculated as

Equity to Asset (A: Mar. 2018 )=Total Stockholders Equity/Total Assets
=290.693/341.103
=0.85

Abaxis's Equity to Asset Ratio for the quarter that ended in Mar. 2018 is calculated as

Equity to Asset (Q: Mar. 2018 )=Total Stockholders Equity/Total Assets
=290.693/341.103
=0.85

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Abaxis  (NAS:ABAX) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Abaxis Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Abaxis's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Abaxis (Abaxis) Business Description

Traded in Other Exchanges
N/A
Address
Abaxis Inc manufactures point-of-care blood analysis instruments and consumables for medical and veterinary care providers. The medical segment sells Piccolo Chemistry Analyzers, which can provide results about a blood sample in 12 minutes, and related reagents to physicians, hospitals, pharmacies, and other healthcare providers. The veterinary segment generates the majority of the firm's total revenue and sells products to animal hospitals, veterinary clinics, and private research laboratories. Products in this segment include the VetScan VS2 chemistry analyzer, animal-specific reagents, and rapid tests for canine and feline diseases. The vast majority of the firm's revenue comes from North America and Europe.
Executives
Richard Bastiani director C/O ABAXIS INC, 3240 WHIPPLE RD, UNION CITY CA 94587
Taylor Dean Ross Jr officer: CFO and VP of Finance C/O ABAXIS INC, 3240 WHIPPLE ROAD, UNION CITY CA 94587
Clinton Severson director, officer: CEO & Board Chairman C/O ABAXIS INC, 3240 WHIPPLE ROAD, UNION CITY CA 94587
Michael D Casey director ALLOS THERAPEUTICS, INC., 11080 CIRCLEPOINT ROAD, SUITE 200, WESTMINSTER CO 80020